School of Medicine


Showing 1-42 of 42 Results

  • Neil M. Kalwani

    Neil M. Kalwani

    Clinical Instructor, Medicine - Cardiovascular Medicine

    BioNeil Kalwani, MD, MPP is a Clinical Instructor in the Division of Cardiovascular Medicine and Director of Preventive Cardiology at the VA Palo Alto Health Care System. He attended college at Yale University and completed graduate degrees in medicine and public policy at Harvard University. He trained in internal medicine at Brigham and Women’s Hospital before arriving at Stanford in 2018 for fellowship in cardiovascular medicine, during which he served as Chief Fellow. He then completed a postdoctoral fellowship through the Stanford-AHRQ Health Services Research Training Program in the Department of Health Policy. His clinical focus is in general and preventive cardiology and echocardiography. He practices at the VA Palo Alto Health Care System and at Stanford Health Care.

    Dr. Kalwani's research focuses on the evaluation of policies and care delivery innovations designed to improve the value of care for patients with cardiovascular disease.

  • Guson Kang

    Guson Kang

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.

    A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital.

  • Peter Kao

    Peter Kao

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly InterestsOur research program has several active projects:
    1.) Pulmonary Vascular Disease – Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
    2.) Lung inflammation and regeneration (stem cells)
    3.) Lung surfactant rheology and oxidative stress
    4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms

  • Michael S. Kapiloff, MD, PhD

    Michael S. Kapiloff, MD, PhD

    Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.

    URL to NCBI listing of all published works:
    http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending

    For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html

  • Ioannis Karakikes

    Ioannis Karakikes

    Associate Professor (Research) of Cardiothoracic Surgery

    Current Research and Scholarly InterestsThe Karakikes Lab aims to uncover fundamental new insights into the molecular mechanisms and functional consequences of pathogenic mutations associated with familial cardiovascular diseases.

  • Karthikeshwar Kasirajan (Kasi)

    Karthikeshwar Kasirajan (Kasi)

    Clinical Professor, Surgery - Vascular Surgery

    BioDr. Kasirajan is a board-certified, fellowship-trained vascular surgeon. Also known as Dr. Kasi, he is a clinical professor of vascular surgery at Stanford University School of Medicine.

    Dr. Kasirajan preserves limbs, facilitates access to dialysis, and helps his patients manage conditions such as aneurysms, varicose veins, thoracic outlet syndrome, and deep vein thrombosis. Many of his limb preservation patients smoke, have diabetes, or are experiencing renal failure. Dr. Kasirajan’s experience also centers around the treatment of aneurysms and prevention of strokes.

    In all cases, his goal is to provide either noninvasive or minimally invasive management whenever possible. He performs open surgery only when it is the best option. Dr. Kasirajan treats many patients with stents and stent grafts, which can shorten hospital stays and recovery times.

    Dr. Kasirajan (Kasi) receives referrals of patients from primary care physicians, nephrologists, podiatrists, cardiologists, woundcare specialists, diabetologists, neurologists, and other specialists. He welcomes referrals as early as possible, ideally before patients become symptomatic. A strong proponent of doing early screening for peripheral artery disease, Dr. Kasirajan advocates for the use of the ankle-brachial index (ABI) in routine physical examinations. When providers detect an imbalance between leg and arm blood pressure, Dr. Kasirajan can help create customized strategies to address the cause before the problem worsens.

    In addition to offering excellent vascular care to the community, Dr. Kasirajan joined Stanford to continue pursuing his research interests. He has conducted research into advances in minimally invasive procedures for stroke prevention and for aneurysm management. His research has also focused on how to improve surgery outcomes to help patients suffering from peripheral vascular disease. Dr. Kasirajan has been the investigator in over 40 multicenter studies involving new stent graphs, thrombectomy catheters, and other advances in endovascular technology.

    Dr. Kasirajan has made more than 100 presentations worldwide on minimally invasive vascular surgery techniques and preventive care in the vascular patient. He has spoken at multiple conferences including the Society for Vascular Surgery, Peripheral Vascular Society, and the South Asian American Vascular Society. He has earned numerous honors for his academic achievements, including the prestigious Alpha Omega Alpha award for medical student and resident education.

    As the author of more than 120 journal articles, Dr. Kasirajan’s work has appeared in the Journal of Vascular Surgery, Endovascular Today, Pharmacogenomics Journal, Catheter Cardiovascular Intervention, and many other publications. He also has authored 20 book chapters in textbooks including Medical Management of the Surgical Patient 5th Edition, Advances in Phlebology and Venus Surgery Volume 1, Current Therapy in Vascular Surgery, Mastery of Surgery, and many more.

    Dr. Kasirajan has served on the editorial boards of the Journal of Endovascular Therapy, Annals of Vascular Surgery, International Journal of Angiology, and other publications.

  • Daniel Katz

    Daniel Katz

    Instructor, Medicine - Cardiovascular Medicine

    BioDaniel Katz is an Instructor of Medicine and an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. Since medical school, his research has focused on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.

  • Masataka Kawana

    Masataka Kawana

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He sees advanced heart failure patients in the clinic and attends CCU/heart failure service, and post-heart transplant and MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy in inherited cardiomyopathy and also conducting a device study in heart failure.

  • Mark A. Kay, M.D., Ph.D.

    Mark A. Kay, M.D., Ph.D.

    Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics

    Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

  • Abha Khandelwal

    Abha Khandelwal

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
    Valvular Heart Disease
    Cardiomyopathy
    Pericardial disease
    Heart Disease in South Asians
    Women's Cardiovascular Disease

  • Butrus Khuri-Yakub

    Butrus Khuri-Yakub

    Professor (Research) of Electrical Engineering, Emeritus

    BioButrus (Pierre) T. Khuri-Yakub is a Professor of Electrical Engineering at Stanford University. He received the BS degree from the American University of Beirut, the MS degree from Dartmouth College, and the Ph.D. degree from Stanford University, all in electrical engineering. His current research interests include medical ultrasound imaging and therapy, ultrasound neuro-stimulation, chemical/biological sensors, gas flow and energy flow sensing, micromachined ultrasonic transducers, and ultrasonic fluid ejectors. He has authored over 600 publications and has been principal inventor or co-inventor of 107 US and international issued patents. He was awarded the Medal of the City of Bordeaux in 1983 for his contributions to Nondestructive Evaluation, the Distinguished Advisor Award of the School of Engineering at Stanford University in 1987, the Distinguished Lecturer Award of the IEEE UFFC society in 1999, a Stanford University Outstanding Inventor Award in 2004, Distinguished Alumnus Award of the School of Engineering of the American University of Beirut in 2005, Stanford Biodesign Certificate of Appreciation for commitment to educate, mentor and inspire Biodesgin Fellows, 2011, and 2011 recipient of IEEE Rayleigh award.

  • Kiran Kaur Khush, MD

    Kiran Kaur Khush, MD

    Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Khush'’s clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.

  • Joel Killen

    Joel Killen

    Professor (Research) of Medicine (General Internal Medicine), Emeritus

    Current Research and Scholarly InterestsMy research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.

  • Dan Seung Kim, MD, PhD, MPH

    Dan Seung Kim, MD, PhD, MPH

    Fellow in Medicine
    Resident in Medicine

    Current Research and Scholarly InterestsMy research projects within the laboratory of Euan Ashley center around the broad topic of exercise, physiology, and cardiovascular disease:
    1. Digital health interventions - I previously have published on the topic of digital health interventions delivered via an iPhone app (Kim and Javed et al, European Heart Journal - Digital Health 2023). We found that personalizing interventions based on individual's baseline activity was more effective in increasing short-term physical activity than other "one-size fits all" approaches. In our next phase, we will extend this to under-represented populations in digital health and implement cutting-edge artificial intelligence models to improve our interventions.
    2. Molecular mechanisms of exercise physiologic adaptations - using time-series multi-omic data, we aim to map out the molecular responses to endurance exercise training in rats, using data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC). See our recent review in Nature Reviews Genetics - Kim et al, 2021.
    3. Effect of physical activity on coronary artery disease symptoms and outcomes - in collaboration with Dr David Maron and the ISCHEMIA study, I am investigating the effects of physical activity and sedentary behavior on symptoms related to known coronary heart disease and separately, the outcome of all-cause mortality.
    4. Exercise [hysiology - in collaboration with Dr Francois Haddad and Dr Jonathan Myers, I am working on projects to better standardize reporting of maximal oxygen uptake. In brief, maximal oxygen uptake (VO2 max) is an extremely valuable prognostic, but estimation of this physiologic value is poor in certain populations. We are working to improve estimation of this variable and demonstrating its efficacy in predicting hard outcomes in patients with heart failure.
    5. Outcomes in inherited cardiomyopathies - under the mentorship of Dr Euan Ashley, I am building my clinical expertise in treating patients with inherited cardiomyopathies. The Stanford Center for Inherited Cardiovascular Disease (SCICD) is home to clinical care of patients with inherited cardiomyopathies, channelopathies, inherited lipid disorders, neuromuscular disorders (e.g., muscular dystrophy), and vascular disorders (e.g., Marfan's and other aorthopathies). Our clinic is nested within the Heart Failure program and manages those patients who are progressing toward advanced heart failure therapies, such as transplant or left ventricular assist devices. Within this clinic, I am leading projects to describe our experience with mavacamten, a first of its class treatment of hypertrophic cardiomyopathy with obstruction.

  • Gloria S. Kim

    Gloria S. Kim

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsMedical education
    Health services delivery
    Management of chronic disease
    Patient and physician satisfaction

  • Juyong Brian Kim

    Juyong Brian Kim

    Assistant Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
    (http://kimlab.stanford.edu)

  • Seung K. Kim  M.D., Ph.D.

    Seung K. Kim M.D., Ph.D.

    KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)

    Current Research and Scholarly InterestsWe study the development of pancreatic islet cells using molecular, embryologic and genetic methods in several model systems, including mice, pigs, human pancreas, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. These approaches have informed efforts to generate replacement islets from renewable sources for diabetes.

  • Abby C. King

    Abby C. King

    David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)

    Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.

  • Derek M. Klarin, MD

    Derek M. Klarin, MD

    Assistant Professor of Surgery (Vascular Surgery)

    BioDr. Klarin is a fellowship-trained vascular surgeon.

    For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to help each patient achieve the best possible health and quality of life.

    Dr. Klarin performs the full spectrum of diagnostic and treatment procedures for cardiovascular conditions. He treats carotid disease, peripheral artery disease, abdominal aortic aneurysm, venous thromboembolism, and other vascular diseases.

    To help advance his field, Dr. Klarin has conducted research. The American Heart Association, Howard Hughes Medical Institute, and other organizations have provided grants to support his studies. He also has co-patented advances in predicting and scoring risk factors for cardiovascular disease and other conditions.

    He has published extensively and co-authored more than 50 articles on new techniques and technology for diagnosing and treating cardiovascular disorders. His work has appeared in the Journal of Vascular Surgery, Circulation, JAMA, Nature Medicine, and other peer-reviewed journals.

    He also has made many invited presentations to his peers. He has spoken at the Vascular Research Initiatives Conference presented by the Society for Vascular Surgery, the American Heart Association Scientific Sessions, and the annual meeting of the American Society for Human Genetics. Topics include risk factors for peripheral artery disease, the benefits of ultrasound screening for abdominal aortic aneurysm, and the impact of genetic variations on cardiovascular disease.

    He is a member of the Global Lipids Genetics Consortium. He is a founding member of the Abdominal Aortic Aneurysm Genetics Consortium and the Peripheral Artery Disease Genetics Consortium. He is also a candidate member of the Society for Vascular Surgery.

  • Joshua W. Knowles

    Joshua W. Knowles

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsGenetic basis of coronary disease
    Genetic basis of insulin resistance
    Familial Hypercholesterolemia (FH)

  • Lisa Marie Knowlton, MD, MPH, FACS, FRCSC

    Lisa Marie Knowlton, MD, MPH, FACS, FRCSC

    Associate Professor of Surgery (General Surgery)

    BioDr. Knowlton is a trauma and critical care surgeon and NIH funded public health researcher whose focus is on improving access to and quality of care for trauma and surgical patients. She obtained her medical degree at McGill University and completed her general surgery residency at the University of British Columbia in Vancouver, Canada. Her desire to understand varied healthcare systems and develop solutions for vulnerable surgical populations led her to obtain an M.P.H. at the Harvard T.H. Chan School of Public Health and complete a research fellowship at the Harvard Humanitarian Initiative. Most recently, she trained as a Surgical Critical Care fellow at Stanford University Medical Center and joined the faculty as an Assistant Professor of Surgery in early 2018.

    Dr. Knowlton's research focuses on improving health equity, addressing barriers in access to care and reducing disparities among vulnerable surgical populations, including underinsured trauma patients. She is also investigating the financial burden that injury imposes upon both patients and hospitals, with the goal of finding economically sustainable strategies for ensuring best outcomes among trauma patients. These include the study of emergency Medicaid programs at the state and national level. Dr. Knowlton’s work has been funded by the American College of Surgeons (the 17th C. James Carrico Faculty Research Fellowship), the American Association for the Surgery of Trauma (AAST) and the NIH. She has received an R21 by the National Institute on Minority Health and Health Disparities, and most recently an R01 for her work (2023-2028). Dr. Knowlton is board certified by the American Board of Surgery and the Royal College of Physicians and Surgeons of Canada. She is a member of the AAST Diversity and Inclusion and Healthcare Economics Committees, and also serves on the Association for Academic Surgery’s Publications Committee. She was the inaugural Chair of the Associate Member Council of the AAST and currently serves as the Associate Vice Chair of Research for the Stanford Department of Surgery. She was recently recognized by the AAST by receiving the 2023 Canizaro award for best presentation and manuscript at the annual meeting. Dr. Knowlton was also selected as the 2023-24 U.S. recipient of the James IV Surgical Association Traveling Fellowship.

  • Brian Kobilka

    Brian Kobilka

    Hélène Irwin Fagan Chair of Cardiology

    Current Research and Scholarly InterestsStructure, function and physiology of adrenergic receptors.

  • Katherine C. Konvinse, MD, PhD

    Katherine C. Konvinse, MD, PhD

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Pediatrics

    BioKatherine Konvinse, MD, PhD is a resident physician in the Stanford Pediatric Residency Research Track Program. She completed her MD and PhD training at Vanderbilt University School of Medicine. Her current research focuses on characterizing the serum antibody responses in pediatric patients exposed to viral infections including COVID-19 and respiratory syncytial virus (RSV) under the mentorship of Professor PJ Utz.

  • Nishita Kothary, MD

    Nishita Kothary, MD

    Professor of Radiology (Interventional Radiology)

    Current Research and Scholarly InterestsInterventional Oncology: Percutaneous and transarterial interventions for diagnosis and treatment of primary and metastatic tumors (lung, liver and renal)


    Research Interest:
    Gastrointestinal and Hepatic Oncology

  • Gregory Kovacs

    Gregory Kovacs

    Professor of Electrical Engineering, Emeritus

    Current Research and Scholarly InterestsHis present research areas include instruments for biomedical and biological applications including space flight, solid-state sensors and actuators, cell-based sensors for toxin detection and pharmaceutical screening, microfluidics, electronic interfaces to tissue, and biotechnology, all with emphasis on solving practical problems.

  • Fredric Kraemer

    Fredric Kraemer

    Gerald M. Reaven, MD, Professor of Endocrinology, Emeritus

    Current Research and Scholarly InterestsOur research interests are in the general area of cellular lipid and lipoprotein metabolism. The work is aimed primarily at understanding the mechanisms regulating cholesterol and triglyceride accumulation in cells. We utilize a variety of techniques from cell biology, biochemistry, and molecular biology.

  • Mark Krasnow

    Mark Krasnow

    Paul and Mildred Berg Professor

    Current Research and Scholarly Interests- Lung development and stem cells
    - Neural circuits of breathing and speaking
    - Lung diseases including lung cancer
    - New genetic model organism for biology, behavior, health and conservation

  • Thomas M. Krummel, MD, FACS/FAAP

    Thomas M. Krummel, MD, FACS/FAAP

    Emile Holman Professor, Emeritus

    Current Research and Scholarly InterestsSurgical Innovation, Simulation and Virtual Reality in Surgical Education, Fetal Healing-Cellular and Biochemical Mechanisms

  • Kristina Kudelko

    Kristina Kudelko

    Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, acute kidney injury in pulmonary arterial hypertension

  • Ellen Kuhl

    Ellen Kuhl

    Walter B Reinhold Professor in the School of Engineering, Robert Bosch Chair of Mechanical Engineering, Professor of Mechanical Engineering and, by courtesy, of Bioengineering

    Current Research and Scholarly Interestscomputaitonal simulation of brain development, cortical folding, computational simulation of cardiac disease, heart failure, left ventricular remodeling, electrophysiology, excitation-contraction coupling, computer-guided surgical planning, patient-specific simulation

  • Calvin Kuo

    Calvin Kuo

    Maureen Lyles D'Ambrogio Professor

    Current Research and Scholarly InterestsWe study cancer biology, intestinal stem cells (ISC), and angiogenesis. We use primary organoid cultures of diverse tissues and tumor biopsies for immunotherapy modeling, oncogene functional screening and stem cell biology. Angiogenesis projects include blood-brain barrier regulation, stroke therapeutics and anti-angiogenic cancer therapy. ISC projects apply organoid culture and ko mice to injury-inducible vs homeostatic stem cells and symmetric division mechanisms.

  • WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE

    WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE

    Professor of Radiology (Interventional Radiology)

    Current Research and Scholarly Interests1) LASER-ASSISTED AND COMPLEX IVC FILTER RETRIEVAL
    2) CATHETER-DIRECTED THERAPY FOR ACUTE PULMONARY EMBOLISM
    3) INTERNATIONAL PE REGISTRY
    4) IVC FILTER REGISTRY
    5) ENDOVASCULAR TREATMENT OF CAVAL AND DEEP VENOUS THROMBOSIS